First Allogenic Stem Cell/Bone Marrow Transplant major done at SKIMS
Srinagar: For the first time in the Union Territory (UT) of Jammu and Kashmir the department of Clinical haematology in the S K Institute of Medical Sciences (SKIMS) performed a matched sibling Allogenic Stem Cell/Bone Marrow Transplant for a patient suffering from Beta Thalassemia Major.
Assistant Director Public Relations (ADPR) Kulsoom Bhat said earlier the department had performed the first Stem/Bone Marrow Transplant on patient suffering from Aplastic Anemia.
Dr Javid Rasool Bhat, Prof and Head Clinical Haematology Department, informed that an eight-year-old boy from Bihar (class Ist student) diagnosed as Beta Thalassemia major at the age of 8 months was evaluated at AIIMS, New Delhi and was offered Bone Marrow Transplant as curative therapy.
The approximate cost of this procedure was quoted as Rs 10 lakhs. Since, patient belongs to a very poor family and could not afford this costly treatment and he was brought by his parents to the Department of Clinical Haematology at SKIMS for his treatment.
She said the only curative treatment option for him was Stem Cell Transplantation. Fortunately, his sister’s bone marrow stem cells were found to be matching. So, patient was taken for Allogenic matched sibling transplant on December 30, 2020. Presently, patient is doing well and is being planned for discharge in few days. Dr. Javaid thanked Director SKIMS for all the support and said this will raise new hope for poor and deserving patients who need Bone Marrow Transplant.
Director SKIMS, Dr AG Ahangar, complimented the whole Department of Clinical Haematology including faculty members: Dr Sajad Geelani Additional Prof, Dr Reashma Roshan Assistant Prof, Dr Afaq Ahmad Khan Asstt Prof and Senior Residents (both Clinical & Lab. side), Resident staff as well as Paramedical Staff of Ward 5P, technical staff (lab. side) and office staff of Clinical Hematology Department including all other supportive Departments. He said SKIMS has created niche in conducting rare procedures which is benefitting poor patients.